Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 13 | Barnes Wendy LynnDirector, See Remarks | Option exercise | M | — 115.1K sh | Apr 15, 2026 |
| 13 | Yuan Eric S.Director, Chief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $46K 550 sh | Apr 15, 2026 traded Apr 14, 2026 |
| 13 | Barnes Wendy LynnDirector, See Remarks | Option exercise | M | — 111.0K sh | Apr 15, 2026 traded Apr 15, 2026 |
| 13 | Yi StevenDirector, See Remarks | Open-market sale · 10b5-1 plan | SELL | $39K 4,000 sh | Apr 15, 2026 traded Apr 15, 2026 |
| 13 | Siebel Thomas MDirector, Executive Chairman, 10% Owner | Option exercise · 10b5-1 plan | M | $665K 326.2K sh | Apr 15, 2026 traded Apr 13, 2026 |
| 13 | Merrill GaryChief Financial Officer | Grant or award | A | — 12.3K sh | Apr 15, 2026 traded Apr 13, 2026 |
| 13 | Haines John RSenior Exec Vice President | Option exercise | M | — 1,641 sh | Apr 15, 2026 traded Apr 13, 2026 |
| 13 | Brigido StephenPres., Functional Regeneration | Option exercise | M | — 821 sh | Apr 15, 2026 traded Apr 13, 2026 |
| 13 | Geissler WernerDirector | Tax withholding | F | $32K 4,572 sh | Apr 15, 2026 traded Apr 13, 2026 |
| 13 | Barnes Wendy LynnDirector, See Remarks | Option exercise | M | — 51.2K sh | Apr 15, 2026 traded Apr 15, 2026 |
| 13 | McGinnis Christopher ASee Remarks | Option exercise | M | — 37.0K sh | Apr 15, 2026 traded Apr 15, 2026 |
| 13 | Inrig JulaCHIEF MEDICAL OFFICER | Open-market sale · 10b5-1 plan | SELL | $43K 1,018 sh | Apr 15, 2026 traded Apr 15, 2026 |
| 13 | Hing ChristiCHIEF ACCOUNTING OFFICER | Tax withholding | F | $11K 5,590 sh | Apr 15, 2026 traded Apr 15, 2026 |
| 13 | Yi StevenDirector, See Remarks | Open-market sale · 10b5-1 plan | SELL | $38K 4,000 sh | Apr 15, 2026 traded Apr 14, 2026 |
| 13 | Rodman David MalcomChief Medical Officer | Open-market sale · 10b5-1 plan | SELL | $373K 14.1K sh | Apr 15, 2026 traded Apr 13, 2026 |
| 13 | Yuan Eric S.Director, Chief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $13K 155 sh | Apr 15, 2026 traded Apr 14, 2026 |
| 12 | Gingras Christopher RaymondDirector | Other acquisition or disposition | J | $541 35 sh | Apr 15, 2026 traded Apr 15, 2026 |
| 12 | Saak Aaron WDirector | Grant or award | A | $150K 2,262 sh | Apr 15, 2026 traded Apr 13, 2026 |
| 12 | Wessel MichaelDirector | Grant or award | A | $180K 25.6K sh | Apr 15, 2026 traded Apr 13, 2026 |
| 12 | Morris Philip CDirector | Other acquisition or disposition | J | $1,017 28 sh | Apr 15, 2026 traded Apr 13, 2026 |
| 12 | Gingras Christopher RaymondDirector | Other acquisition or disposition | J | $1,075 43 sh | Apr 15, 2026 traded Apr 15, 2026 |
| 12 | Showalter Christopher MichaelChief Executive Officer | Tax withholding | F | $183K 46.5K sh | Apr 15, 2026 traded Apr 13, 2026 |
| 12 | Maroney Dawn ChristinePresident | Open-market sale · 10b5-1 plan | SELL | $626K 30.0K sh | Apr 15, 2026 traded Apr 15, 2026 |
| 12 | Lee David ChGeneral Counsel & Secretary | Gift | G | — 3,400 sh | Apr 15, 2026 traded Apr 15, 2026 |
| 12 | Bexiga Annabelle GDirector | Open-market sale · 10b5-1 plan | SELL | $153K 1,500 sh | Apr 15, 2026 traded Apr 15, 2026 |
| 12 | Siu Hera KDirector | Grant or award | A | $180K 25.6K sh | Apr 15, 2026 traded Apr 13, 2026 |
| 11 | Fordyce MarshallDirector, PRESIDENT AND CEO | Open-market sale · 10b5-1 plan | SELL | $353K 7,921 sh | Apr 15, 2026 traded Apr 14, 2026 |
| 10 | Rodman David MalcomChief Medical Officer | Open-market sale · 10b5-1 plan | SELL | $176K 6,348 sh | Apr 15, 2026 traded Apr 15, 2026 |
| 9 | Feltheimer JonDirector, Chief Executive Officer | Grant or award | A | — 4.50M sh | Apr 15, 2026 traded Apr 13, 2026 |
| 9 | Haines John RSenior Exec Vice President | Option exercise | M | — 1,641 sh | Apr 15, 2026 traded Apr 13, 2026 |
| 9 | Muzzey DaleChief Scientific Officer | Tax withholding | F | $4,645 946 sh | Apr 15, 2026 traded Apr 14, 2026 |
| 9 | Macomber Sasha G.Chief Human Resource Officer | Option exercise | M | — 8,031 sh | Apr 15, 2026 traded Apr 14, 2026 |
| 9 | Brigido StephenPres., Functional Regeneration | Option exercise | M | — 821 sh | Apr 15, 2026 traded Apr 13, 2026 |
| 9 | Taecker Benjamin S.Chief Eng and Opr Officer | Tax withholding | F | $2,803 715 sh | Apr 15, 2026 traded Apr 13, 2026 |
| 9 | West EricChief Financial Officer | Tax withholding | F | $3,383 863 sh | Apr 15, 2026 traded Apr 13, 2026 |
| 9 | Wahlund Todd RSenior Vice President | Grant or award | A | — 300 sh | Apr 15, 2026 traded Apr 13, 2026 |
| 9 | Siu Hera KDirector | Option exercise | M | — 9,523 sh | Apr 15, 2026 traded Apr 13, 2026 |
| 9 | Abate Christopher JDirector, Chief Executive Officer | Option exercise | M | — 51.4K sh | Apr 15, 2026 traded Apr 14, 2026 |
| 9 | Siu Hera KDirector | Option exercise | M | — 9,523 sh | Apr 15, 2026 traded Apr 13, 2026 |
| 9 | Nelson Tyler JVP, Chief Financial Officer | Grant or award | A | — 800 sh | Apr 15, 2026 traded Apr 13, 2026 |